Report Detail
Global Polypeptide Drug Market Insights and Forecast to 2026
- RnM4158839 |
- 25 August, 2020 |
- Global |
- 115 Pages |
- QYResearch |
- Pharma & Healthcare
Polypeptide Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polypeptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Polypeptide Drug market is segmented into
Injection
Nasal Administration
Lung Administration
Oral Administration
Transdermal Administration
Segment by Application, the Polypeptide Drug market is segmented into
Immunity Regulating Medicine (Allergy Infection and Immune)
Digestive System Drugs (Gastrointestinal Type)
Bone and Connective Tissue Types (Thyroid hormones Drug)
Gynecologic or Obstetric Drug
Tumor Drug
Urinary System Drug
Metabolic Drug (Insulin and Other Hypoglycemic Agents)
Regional and Country-level Analysis
The Polypeptide Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Polypeptide Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Polypeptide Drug Market Share Analysis
Polypeptide Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Polypeptide Drug business, the date to enter into the Polypeptide Drug market, Polypeptide Drug product introduction, recent developments, etc.
The major vendors covered:
Novartis
Merck Serono
Ferring Pharmaceuticals
Ipsen PHarma Biotech
Lilly
Asahi Kasei
AstraZeneca
SciClone Pharmaceuticals
Takeda
Roche
Sanofi
1 Study Coverage
- 1.1 Polypeptide Drug Product Introduction
- 1.2 Market Segments
- 1.3 Key Polypeptide Drug Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Polypeptide Drug Market Size Growth Rate by Type
- 1.4.2 Injection
- 1.4.3 Nasal Administration
- 1.4.4 Lung Administration
- 1.4.5 Oral Administration
- 1.4.6 Transdermal Administration
- 1.5 Market by Application
- 1.5.1 Global Polypeptide Drug Market Size Growth Rate by Application
- 1.5.2 Immunity Regulating Medicine (Allergy Infection and Immune)
- 1.5.3 Digestive System Drugs (Gastrointestinal Type)
- 1.5.4 Bone and Connective Tissue Types (Thyroid hormones Drug)
- 1.5.5 Gynecologic or Obstetric Drug
- 1.5.6 Tumor Drug
- 1.5.7 Urinary System Drug
- 1.5.8 Metabolic Drug (Insulin and Other Hypoglycemic Agents)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Polypeptide Drug Market Size, Estimates and Forecasts
- 2.1.1 Global Polypeptide Drug Revenue 2015-2026
- 2.1.2 Global Polypeptide Drug Sales 2015-2026
- 2.2 Global Polypeptide Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Polypeptide Drug Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Polypeptide Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Polypeptide Drug Competitor Landscape by Players
- 3.1 Polypeptide Drug Sales by Manufacturers
- 3.1.1 Polypeptide Drug Sales by Manufacturers (2015-2020)
- 3.1.2 Polypeptide Drug Sales Market Share by Manufacturers (2015-2020)
- 3.2 Polypeptide Drug Revenue by Manufacturers
- 3.2.1 Polypeptide Drug Revenue by Manufacturers (2015-2020)
- 3.2.2 Polypeptide Drug Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Polypeptide Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Polypeptide Drug Revenue in 2019
- 3.2.5 Global Polypeptide Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Polypeptide Drug Price by Manufacturers
- 3.4 Polypeptide Drug Manufacturing Base Distribution, Product Types
- 3.4.1 Polypeptide Drug Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Polypeptide Drug Product Type
- 3.4.3 Date of International Manufacturers Enter into Polypeptide Drug Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Polypeptide Drug Market Size by Type (2015-2020)
- 4.1.1 Global Polypeptide Drug Sales by Type (2015-2020)
- 4.1.2 Global Polypeptide Drug Revenue by Type (2015-2020)
- 4.1.3 Polypeptide Drug Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Polypeptide Drug Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Polypeptide Drug Sales Forecast by Type (2021-2026)
- 4.2.2 Global Polypeptide Drug Revenue Forecast by Type (2021-2026)
- 4.2.3 Polypeptide Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Polypeptide Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Polypeptide Drug Market Size by Application (2015-2020)
- 5.1.1 Global Polypeptide Drug Sales by Application (2015-2020)
- 5.1.2 Global Polypeptide Drug Revenue by Application (2015-2020)
- 5.1.3 Polypeptide Drug Price by Application (2015-2020)
- 5.2 Polypeptide Drug Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Polypeptide Drug Sales Forecast by Application (2021-2026)
- 5.2.2 Global Polypeptide Drug Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Polypeptide Drug Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Polypeptide Drug by Country
- 6.1.1 North America Polypeptide Drug Sales by Country
- 6.1.2 North America Polypeptide Drug Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Polypeptide Drug Market Facts & Figures by Type
- 6.3 North America Polypeptide Drug Market Facts & Figures by Application
7 Europe
- 7.1 Europe Polypeptide Drug by Country
- 7.1.1 Europe Polypeptide Drug Sales by Country
- 7.1.2 Europe Polypeptide Drug Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Polypeptide Drug Market Facts & Figures by Type
- 7.3 Europe Polypeptide Drug Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Polypeptide Drug by Region
- 8.1.1 Asia Pacific Polypeptide Drug Sales by Region
- 8.1.2 Asia Pacific Polypeptide Drug Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Polypeptide Drug Market Facts & Figures by Type
- 8.3 Asia Pacific Polypeptide Drug Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Polypeptide Drug by Country
- 9.1.1 Latin America Polypeptide Drug Sales by Country
- 9.1.2 Latin America Polypeptide Drug Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Polypeptide Drug Market Facts & Figures by Type
- 9.3 Central & South America Polypeptide Drug Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Polypeptide Drug by Country
- 10.1.1 Middle East and Africa Polypeptide Drug Sales by Country
- 10.1.2 Middle East and Africa Polypeptide Drug Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Polypeptide Drug Market Facts & Figures by Type
- 10.3 Middle East and Africa Polypeptide Drug Market Facts & Figures by Application
11 Company Profiles
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Polypeptide Drug Products Offered
- 11.1.5 Novartis Related Developments
- 11.2 Merck Serono
- 11.2.1 Merck Serono Corporation Information
- 11.2.2 Merck Serono Description and Business Overview
- 11.2.3 Merck Serono Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Merck Serono Polypeptide Drug Products Offered
- 11.2.5 Merck Serono Related Developments
- 11.3 Ferring Pharmaceuticals
- 11.3.1 Ferring Pharmaceuticals Corporation Information
- 11.3.2 Ferring Pharmaceuticals Description and Business Overview
- 11.3.3 Ferring Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Ferring Pharmaceuticals Polypeptide Drug Products Offered
- 11.3.5 Ferring Pharmaceuticals Related Developments
- 11.4 Ipsen PHarma Biotech
- 11.4.1 Ipsen PHarma Biotech Corporation Information
- 11.4.2 Ipsen PHarma Biotech Description and Business Overview
- 11.4.3 Ipsen PHarma Biotech Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Ipsen PHarma Biotech Polypeptide Drug Products Offered
- 11.4.5 Ipsen PHarma Biotech Related Developments
- 11.5 Lilly
- 11.5.1 Lilly Corporation Information
- 11.5.2 Lilly Description and Business Overview
- 11.5.3 Lilly Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Lilly Polypeptide Drug Products Offered
- 11.5.5 Lilly Related Developments
- 11.6 Asahi Kasei
- 11.6.1 Asahi Kasei Corporation Information
- 11.6.2 Asahi Kasei Description and Business Overview
- 11.6.3 Asahi Kasei Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Asahi Kasei Polypeptide Drug Products Offered
- 11.6.5 Asahi Kasei Related Developments
- 11.7 AstraZeneca
- 11.7.1 AstraZeneca Corporation Information
- 11.7.2 AstraZeneca Description and Business Overview
- 11.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 AstraZeneca Polypeptide Drug Products Offered
- 11.7.5 AstraZeneca Related Developments
- 11.8 SciClone Pharmaceuticals
- 11.8.1 SciClone Pharmaceuticals Corporation Information
- 11.8.2 SciClone Pharmaceuticals Description and Business Overview
- 11.8.3 SciClone Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 SciClone Pharmaceuticals Polypeptide Drug Products Offered
- 11.8.5 SciClone Pharmaceuticals Related Developments
- 11.9 Takeda
- 11.9.1 Takeda Corporation Information
- 11.9.2 Takeda Description and Business Overview
- 11.9.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Takeda Polypeptide Drug Products Offered
- 11.9.5 Takeda Related Developments
- 11.10 Roche
- 11.10.1 Roche Corporation Information
- 11.10.2 Roche Description and Business Overview
- 11.10.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Roche Polypeptide Drug Products Offered
- 11.10.5 Roche Related Developments
- 11.1 Novartis
- 11.1.1 Novartis Corporation Information
- 11.1.2 Novartis Description and Business Overview
- 11.1.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Novartis Polypeptide Drug Products Offered
- 11.1.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Polypeptide Drug Market Estimates and Projections by Region
- 12.1.1 Global Polypeptide Drug Sales Forecast by Regions 2021-2026
- 12.1.2 Global Polypeptide Drug Revenue Forecast by Regions 2021-2026
- 12.2 North America Polypeptide Drug Market Size Forecast (2021-2026)
- 12.2.1 North America: Polypeptide Drug Sales Forecast (2021-2026)
- 12.2.2 North America: Polypeptide Drug Revenue Forecast (2021-2026)
- 12.2.3 North America: Polypeptide Drug Market Size Forecast by Country (2021-2026)
- 12.3 Europe Polypeptide Drug Market Size Forecast (2021-2026)
- 12.3.1 Europe: Polypeptide Drug Sales Forecast (2021-2026)
- 12.3.2 Europe: Polypeptide Drug Revenue Forecast (2021-2026)
- 12.3.3 Europe: Polypeptide Drug Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Polypeptide Drug Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Polypeptide Drug Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Polypeptide Drug Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Polypeptide Drug Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Polypeptide Drug Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Polypeptide Drug Sales Forecast (2021-2026)
- 12.5.2 Latin America: Polypeptide Drug Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Polypeptide Drug Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Polypeptide Drug Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Polypeptide Drug Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Polypeptide Drug Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Polypeptide Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Polypeptide Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Polypeptide Drug Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Polypeptide Drug. Industry analysis & Market Report on Polypeptide Drug is a syndicated market report, published as Global Polypeptide Drug Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Polypeptide Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
